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Abstract Antimycin A and 2-heptyl-4-hydroxyquinoline N-
oxide (HQNO), both of which bind to the same site of complex
III, prevented U937 cell killing promoted by tert-butylhydroper-
oxide (tB-OOH). This cytoprotection was not directly caused by
inhibition of electron transport or reduced formation of tB-
OOH-derived toxic species, but rather appeared to be the
consequence of a mechanism involving mitochondrial formation
of hydrogen peroxide. Ubisemiquinone was most likely the
electron donor allowing the formation of superoxides and, as a
consequence, of hydrogen peroxide.
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1. Introduction
The organic hydroperoxide tert-butylhydroperoxide (tB-
OOH) generates reactive intermediates within the cell which
subsequently damage an array of biomolecules including lip-
ids [1], thiols [2,3], DNA [4^8] and proteins [9]. As a conse-
quence, these cells lose their ability to generate ATP [10^13]
and to control cation homeostasis [14,15] and redox equili-
brium [16]. Although the exact mechanism of the lethal re-
sponse is still unknown, mitochondrial damage and the for-
mation of permeability transition pores are currently
considered to be the ¢nal events leading to cell death after
treatment with tB-OOH [11,13,17]. It is therefore important to
identify the nature and the sequence of the upstream events
leading to pore opening and then to cell death. In order to do
so, however, it is ¢rst necessary to identify the tB-OOH-de-
rived cytotoxic intermediates and the subcellular site(s) in
which these species are being formed. Previous studies
[18,19] reported that inhibitors of cytochrome P-450 reduce
the formation of tB-OOH-derived radical species. Other stud-
ies [7,20] showed that the oxygen- and carbon-centered radical
species derived from tB-OOH are at least partially generated
at the level of mitochondria.
The results presented in this paper extend our previous
¢ndings indicating that a high concentration of antimycin A
reduced the formation of these radicals and that this e¡ect
was associated with a small reduction in the cytotoxic re-
sponse [7]. We herein report that the lethal e¡ects promoted
by tB-OOH are prevented by concentrations of antimycin A
and 2-heptyl-4-hydroxyquinoline N-oxide (HQNO) resulting
in inhibition of oxygen consumption. The cytoprotective ef-
fect, however, is not a direct consequence of inhibition of
oxygen consumption or mitochondrial reductive decomposi-
tion of tB-OOH. As previously observed for the potentiation
of tB-OOH-induced DNA cleavage [8], inhibition of cell death
appears to be mediated by the enforced mitochondrial forma-
tion of hydrogen peroxide resulting from dismutation of
superoxide anions generated in a reaction in which ubisemi-
quinone serves as electron donor.
2. Materials and methods
2.1. Cell culture and treatments
U937 cells were grown in RPMI 1640 culture medium (Sigma
Chemical Co., St. Louis, MO, USA) supplemented with 10% (v/v)
fetal bovine serum (Seralab Ltd., Sussex, UK), penicillin (50 units/
ml) and streptomycin (50 Wg/ml), at 37‡C in T-75 tissue culture £asks
(Corning, Corning, NY, USA) in an atmosphere of 95% air-5% CO2.
Respiration-de¢cient U937 cells were isolated by culturing the cells in
RPMI medium containing 110 Wg/ml pyruvate, 5 Wg/ml uridine and
400 ng/ml ethidium bromide or 50 Wg/ml chloramphenicol for 6 days
with medium changes every 2 days. Under these conditions, these cells
were unable to consume oxygen in response to glucose or pyruvate.
A stock solution of tB-OOH was freshly prepared in saline A
(0.14 M NaCl, 5 mM KCl, 4 mM NaHCO3, 5 mM glucose). Metyr-
apone and K-phenyl-K-propylbenzeneacetic acid 2-[diethylamino] eth-
yl ester (SKF 525A) were dissolved in distilled water. Antimycin A,
HQNO and myxothiazol were dissolved in 95% ethanol. At the treat-
ment stage the ¢nal ethanol concentration was never higher than
0.05% and, under these conditions, was neither toxic nor did it a¡ect
the cytotoxic properties of tB-OOH. Treatments were performed in
saline A and the cell density was 2U105 cells/ml.
2.2. Cytotoxicity assay
After the treatments, the cells were washed with saline A and re-
suspended in pre-warmed culture medium, plated into 35-mm tissue
culture dishes and incubated at 37‡C for 6 h. Cytotoxicity was deter-
mined using the trypan blue exclusion assay. Brie£y, an aliquot of the
cell suspension was diluted 1:1 (v/v) with 0.4% trypan blue and the
cells were counted using a haemocytometer. Results are expressed as
the percentage of dead cells calculated as the ratio of stained cells vs.
the total number of cells.
2.3. Oxygen consumption
U937 cells were washed once in saline A and then resuspended in
the same medium at a density of 1U107 cells/ml. Oxygen consumption
was measured using a Y.S.I. oxygraph equipped with a Clark elec-
trode (model 5300, Yellow Springs Instruments Co., Yellow Springs,
OH, USA). The cell suspension (3 ml) was transferred to the polaro-
graphic cell and the oxygen levels were monitored for 3 min under
constant stirring (basal respiration). Each of the di¡erent compounds
(see Sections 3 and 4) was then added and respiration was again
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measured for 3 min. The rate of oxygen utilization was calculated as
described in [21].
3. Results
3.1. Complex III inhibitor-mediated prevention of
tB-OOH-induced cytotoxicity
U937 cell killing induced by a 1 mM concentration of tB-
OOH was prevented by antimycin A and HQNO (Fig. 1A^B),
which are known to inhibit complex III at the level of the
same site [22]. In contrast, the complex III inhibitor myxo-
thiazol ^ which binds to a site di¡erent from that of antimycin
A and HQNO [23] ^ did not a¡ect the toxicity elicited by tB-
OOH (Fig. 1C). The cytoprotection a¡orded by antimycin A
and HQNO was concentration-dependent and apparent over
the same dose-range in which inhibition of oxygen consump-
tion was also observed (Table 1). Increasing the concentra-
tions of antimycin A above 0.5^1 WM, however, resulted in a
progressive appearance of cell killing (Fig. 1A). The results
illustrated in Fig. 2 indicate that low levels of antimycin A
promote death in respiration-pro¢cient cells treated with the
combination 50 WM HQNO/1 mM tB-OOH as well as in
respiration-de¢cient cells treated with 1 mM tB-OOH. The
toxicity curves resulting from these treatments were basically
superimposable regardless of whether the respiration-de¢cient
phenotype was induced by growth in chloramphenicol or ethi-
dium bromide. It is also important to note that the combina-
tion HQNO/tB-OOH, or the hydroperoxide alone, was not
toxic for respiration-pro¢cient (Figs. 2 and 1B) or -de¢cient
(Fig. 2) cells, respectively.
Lastly, we demonstrated that, under the experimental con-
ditions utilized in this study, the mode of cell death caused by
tB-OOH was necrosis and that its prevention by antimycin A,
or HQNO, was not associated with the onset of apoptosis
(not shown). Indeed, the morphological alterations induced
by 1 mM tB-OOH were mainly represented by swelling of
the cells followed by loss of nuclear material, with no evidence
of chromatin condensation or fragmentation. Conventional
electrophoresis revealed that this treatment did not result in
the formation of internucleosomal DNA cleavage. Pulsed ¢eld
gel electrophoresis of the DNA from these cells indicated the
absence of discrete or 50 kilobase paired DNA fragments
which are produced during apoptotic cell death [24], but
rather generated the smeared fragments which are indicative
of necrotic cell death [25]. In marked contrast, most of the
cells treated with the cocktail antimycin A/tB-OOH displayed
normal morphology and DNA fragmentation was not de-
tected using both conventional and pulsed ¢eld gel electro-
phoresis.
Morphological and biochemical analyses revealed the ab-
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Fig. 1. The e¡ect of antimycin A, HQNO or myxothiazol on U937
cell killing induced by tB-OOH. U937 cells (2U105/ml) were ex-
posed to 1 mM tB-OOH for 30 min in saline A after a 5 min pre-
incubation with increasing concentrations of antimycin A (A),
HQNO (B) or myxothiazol (C). After treatments, the cells were
rinsed and post-incubated for 6 h in drug-free culture medium and
then analyzed for cytotoxicity (see Section 2). Results represent the
mean þ S.E.M. calculated from three experiments, each performed in
duplicate. *P6 0.01 and **P6 0.001 vs. treatment with 1 mM tB-
OOH alone (unpaired t-test).
Table 1
The e¡ect of antimycin A, HQNO, myxothiazol, metyrapone or
SKF 525A on U937 cell oxygen consumption
Treatment (WM) nmol O2/min/107 cells
^ 12.83
Antimycin A
0.1 5.59
0.3 3.31
0.5 1.37
HQNO
1 7.84
3 3.91
10 0.92
Myxothiazol
0.5 4.64
1 2.76
10 0.67
Metyrapone
500 12.94
SKF 525A
75 12.49
The cells were rinsed with saline A and then analyzed for oxygen
consumption as described in Section 2. The rate of oxygen consump-
tion was monitored for 3 min at the beginning of the experiment
(basal respiration) and after addition of the drugs. Results represent
the mean of two separate experiments.
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sence of apoptosis in respiration-de¢cient cells treated with
1 mM tB-OOH.
3.2. Cytochrome P-450 inhibitor-mediated prevention of
tB-OOH-induced cytotoxicity
The e¡ect of inhibitors of cytochrome P-450 on U937 cell
killing induced by 1 mM tB-OOH was investigated. As illus-
trated in Fig. 3, metyrapone as well as SKF 525A e⁄ciently
prevented the toxic response evoked by the hydroperoxide.
The cytoprotection a¡orded by these inhibitors was concen-
tration-dependent and the lethal response evoked by the hy-
droperoxide was abolished by 250 WM metyrapone or 75 WM
SKF 525A. It is important to note that, under the experimen-
tal conditions utilized in this study, neither of these two in-
hibitors produced signi¢cant e¡ects on oxygen consumption
(Table 1).
3.3. The complex III inhibitor-mediated prevention of
tB-OOH-induced cytotoxicity is causally linked to
enforced formation of hydrogen peroxide
The possibility that enforced formation of hydrogen perox-
ide in complex III-inhibited cells is responsible for the reduced
tB-OOH-induced toxic response was investigated. Myxothia-
zol inhibits the electron £ow from the reduced coenzyme Q to
cytochrome c1 and therefore prevents the formation of ubise-
miquinone [26]. Since ubisemiquinone is most likely the elec-
tron donor in antimycin A (or HQNO)-treated cells [8], we
investigated the e¡ect of myxothiazol on the antimycin A-
mediated prevention of the tB-OOH-induced cytotoxic re-
sponse. The cells were therefore sequentially treated with
5 WM myxothiazol, 0.5 WM antimycin A and 1 mM tB-
OOH. As illustrated in Table 2, preventing the formation of
ubisemiquinone with myxothiazol abolished the cytoprotec-
tive e¡ects of antimycin A.
The results reported in Table 2 also indicate that the tox-
icity of tB-OOH was prevented by a nontoxic level of reagent
hydrogen peroxide (500 WM) or by cyclosporin A (0.5 WM).
FEBS 20527 20-7-98
Fig. 2. The e¡ect of antimycin A on cell killing induced by tB-OOH
in respiration-pro¢cient HQNO-supplemented cells or in respiration-
de¢cient cells. Cells made respiration-de¢cient by growth in either
ethidium bromide (closed circles) or chloramphenicol (closed trian-
gles) were exposed to 1 mM tB-OOH for 30 min in saline A after a
5 min pre-incubation with increasing concentrations of antimycin A.
Respiration-pro¢cient cells were treated for 5 min with 50 WM
HQNO, for an additional 5 min with increasing concentrations of
antimycin A and then for 30 min with 1 mM tB-OOH (open
circles). After treatments, the cells were rinsed and post-incubated
for 6 h in drug-free culture medium and then analyzed for cytotox-
icity. Results represent the mean þ S.E.M. calculated from 3^4 ex-
periments, each performed in duplicate. *P6 0.0002 vs. treatment
with 1 mM tB-OOH in HQNO-supplemented respiration-pro¢cient
cells or treatment with 1 mM tB-OOH in respiration-de¢cient cells
(unpaired t-test).
Fig. 3. The e¡ect of metyrapone or SKF 525A on U937 cell killing
induced by tB-OOH. U937 cells (2U105/ml) were exposed to 1 mM
tB-OOH for 30 min in saline A after a 5 min pre-incubation with
increasing concentrations of either metyrapone (open circles) or
SKF 525A (closed circles). After treatments, the cells were rinsed
and post-incubated for 6 h in drug-free culture medium and then
analyzed for cytotoxicity (see Section 2). Results represent the
mean þ S.E.M. calculated from three experiments, each performed in
duplicate. *P6 0.01 and **P6 0.001 vs. treatment with 1 mM tB-
OOH alone (unpaired t-test).
Table 2
The e¡ect of myxothiazol on the antimycin A-mediated prevention of the tB-OOH-induced cytotoxicity
Treatment Cell death (%)
1 mM tB-OOH 57.8 þ 5.7
1 mM tB-OOH+5 WM myxothiazol 60.3 þ 2.2
1 mM tB-OOH+5 WM antimycin A 10.2 þ 0.5*
1 mM tB-OOH+5 WM myxothiazol+0.5 WM antimycin A 61.9 þ 4.5
1 mM tB-OOH+500 WM H2O2 18.5 þ 1.8*
1 mM tB-OOH+0.5 WM cyclosporin A 8.1 þ 1.1*
The cells were treated for 30 min with tB-OOH in the absence or presence of antimycin A and/or myxothiazol. The sequence of addition of
these compounds was the same as that detailed in the legend to Fig. 2. Also shown is the e¡ect of cyclosporin A or H2O2 on the toxicity promoted
by the hydroperoxide. Cyclosporin A or H2O2 was given to the cultures 5 min prior to addition of tB-OOH. After treatments, the cells were rinsed
and post-incubated for 6 h in drug-free culture medium and then analyzed for cytotoxicity (see Section 2). Antimycin A, myxothiazol, cyclosporin
A and H2O2 were not toxic when given alone to the cultures. Results represent the mean þ S.E.M. calculated from three experiments, each
performed in duplicate and were signi¢cantly di¡erent from those for cytotoxicity generated by the hydroperoxide alone at *P6 0.002 (unpaired
t-test).
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4. Discussion
The results presented in this study indicate that the complex
III inhibitors antimycin A and HQNO (Fig. 1A^B) ^ but not
myxothiazol (Fig. 1C) ^ prevent the necrotic response induced
by tB-OOH. Prevention of necrosis was not associated with a
switch to apoptosis (not shown) and was apparent over the
same dose-range in which inhibition of oxygen consumption
was also observed (Table 1). The e¡ect of antimycin A, how-
ever, was biphasic in nature since nanomolar levels of this
inhibitor e¡ectively reduced the toxic response elicited by
the hydroperoxide, whereas under the same conditions a pro-
gressive appearance of dead cells was observed using micro-
molar concentrations of antimycin A (Fig. 1A). While the
exact mechanism mediating this e¡ect of antimycin A remains
to be elucidated, two lines of evidence suggest that the onset
of the lethal response was caused by toxic species resulting
from the interaction of tB-OOH (or tB-OOH-derived radical
species) with the fraction of antimycin A not bound to com-
plex III. First, cytotoxicity was detected in cells pre-treated
with a concentration of HQNO abolishing oxygen consump-
tion (and possibly saturating the complex III binding sites)
and then exposed to very low levels of antimycin A and
1 mM tB-OOH (Fig. 2). Under these conditions HQNO pre-
vented the toxicity of tB-OOH and the addition of antimycin
A, at concentrations which are cytoprotective in the absence
of HQNO, promoted cell death. Secondly, cells made respira-
tion-de¢cient by growth in either chloramphenicol or ethidi-
um bromide were on the one hand resistant [27] to the toxicity
induced by 1 mM tB-OOH (which results in approx. 50% cell
death in respiration-pro¢cient cells), but on the other hand
were e⁄ciently killed by the hydroperoxide associated with
nanomolar levels of antimycin A (Fig. 2). Thus, the same
concentrations of antimycin A which were cytoprotective in
respiration-pro¢cient cells promoted cell death in respiration-
de¢cient cells challenged with a subtoxic level of tB-OOH.
These results therefore indicate that two stoichiometric in-
hibitors of complex III abolish the lethal e¡ects of tB-OOH
and provide an explanation for the small and transient pro-
tective e¡ect previously observed using 5 WM antimycin A [7].
Although these e¡ects were observed at the same concentra-
tions producing inhibition of oxygen utilization, the possibil-
ity that interruption of electron transport in the respiratory
chain is causally linked to cytoprotection is unlikely since, at
levels abolishing oxygen utilization (Table 1), the complex III
inhibitor myxothiazol ^ which binds to a site di¡erent from
that of antimycin A and HQNO [23] ^ did not a¡ect the
toxicity elicited by tB-OOH (Fig. 1C).
Taken together, the results thus far discussed indicate that
inhibition of oxygen consumption does not in and of itself
reduce the toxicity promoted by tB-OOH. Rather, it would
appear that cell killing is prevented by the binding of antimy-
cin A or HQNO to their speci¢c sites in complex III.
In principle, this binding may prevent the mitochondrial
formation of tB-OOH-derived toxic radical species. This pos-
sibility is supported by the work of O’Donnel and Burkitt [20]
which suggested that the mitochondrial electron-transport
chain plays an important role in the reduction of tB-OOH
to free radical(s) and, in particular, identi¢ed a species inhib-
itable by antimycin A. Using intact U937 cells, we also dem-
onstrated that antimycin A reduces the formation of tert-bu-
toxyl as well as methyl radicals [7].
In order to assess whether the complex III-mediated reduc-
tion of tB-OOH was critical for the onset of the cytotoxic
response, we investigated the e¡ect of inhibitors of cyto-
chrome P-450, which were also reported to reduce the forma-
tion of tB-OOH-derived radical species [18,19]. Metyrapone as
well as SKF 525A e⁄ciently prevented the U937 cell killing
induced by 1 mM tB-OOH (Fig. 3) but did not a¡ect oxygen
consumption (Table 1). This ¢nding on the one hand rules out
the possibility that prevention of tB-OOH toxicity is due to
nonspeci¢c interaction of these inhibitors with the antimycin
A binding site in complex III, and on the other hand supports
the notion that cytoprotection can be dissociated from inhib-
ition of electron transport (see above). The most important
information emerging from these experiments, however, is
that the mechanism whereby antimycin A and HQNO prevent
the cell killing generated by tB-OOH cannot be entirely ex-
plained by prevention of the complex III-mediated reduction
of tB-OOH.
Unlike cytotoxicity, the DNA cleavage generated by tB-
OOH is enhanced by antimycin A and HQNO, and this re-
sponse is mediated by enforced mitochondrial formation of
hydrogen peroxide [8]. These inhibitors, by preventing the
electron £ow from reduced cytochrome b562 to oxidized coen-
zyme Q, promote the formation of superoxides and, as a
consequence, of hydrogen peroxide. Although these experi-
ments were performed using a nontoxic concentration of tB-
OOH (200 WM) we can however assume that the same events
will occur in antimycin A/HQNO-supplemented cells exposed
to lethal levels of the hydroperoxide. Thus, under conditions
in which the complex III inhibitors prevent the toxicity of tB-
OOH, a parallel accumulation of superoxides and hydrogen
peroxides will most likely occur.
These results therefore suggest that hydrogen peroxide, and
the resulting DNA single strand breakage, either does not
play a signi¢cant role in tB-OOH-induced cell death or is
involved in the antimycin A/HQNO-mediated protective re-
sponse.
In the present study we report that myxothiazol, which
prevents the formation of ubisemiquinone [26], abolished the
cytoprotective e¡ects of antimycin A (Table 2). Since the for-
mation of ubisemiquinone is expected to promote formation
of hydrogen peroxide, these results strongly suggest that the
oxidant mediates the cytoprotection a¡orded by antimycin A
in cells challenged with toxic levels of tB-OOH. The ¢nding
that a nontoxic level of reagent hydrogen peroxide reduced
the cell killing induced by tB-OOH (Table 2) is consistent with
this mechanism.
Finally, we have provided (Table 2) indirect experimental
evidence that, under the conditions utilized in the present
study, the formation of permeability transition pores mediates
the toxicity evoked by tB-OOH since this response was pre-
vented by cyclosporin A (0.5 WM), an agent which binds to
cyclophillin, thereby preventing pore opening [28].
Thus, our results are in apparent contradiction with the
¢ndings of Castilho et al. [17] indicating that in isolated mi-
tochondria the permeability transition caused by tB-OOH is
mediated by hydrogen peroxide. Using experimental condi-
tions under which the formation of permeability transition
pores was the ¢nal event leading to U937 cell death after
treatment with tB-OOH (Table 2), we now report that mito-
chondrial formation of hydrogen peroxide is causally linked
to the antimycin A-mediated prevention of the toxicity evoked
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by tB-OOH. Although the mechanism(s) involved in these
e¡ects are currently unknown, it is possible that cytoprotec-
tion occurs as a result of mobilization of antioxidant defences
[29].
In conclusion, the results presented in this study demon-
strate that the binding of antimycin A, or HQNO, to complex
III of tB-OOH-treated U937 cells leads to mitochondrial for-
mation of hydrogen peroxide, which then mediates prevention
of the toxic response evoked by the hydroperoxide. Experi-
ments are in progress to elucidate the mechanism whereby low
levels of hydrogen peroxide promote cytoprotection in cells
injured with tB-OOH.
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